authors: "Yonesaka K, Zejnullahu K, Okamoto I, Satoh T, Cappuzzo F, Souglakos J, Ercan\
  \ D, Rogers A, Roncalli M, Takeda M, Fujisaka Y, Philips J, Shimizu T, Maenishi\
  \ O, Cho Y, Sun J, Destro A, Taira K, Takeda K, Okabe T, Swanson J, Itoh H, Takada\
  \ M, Lifshits E, Okuno K, Engelman JA, Shivdasani RA, Nishio K, Fukuoka M, Varella-Garcia\
  \ M, Nakagawa K, J\xE4nne PA."
counts:
  biosamples: 70.0
  samples_acgh: 70.0
  samples_ccgh: 0.0
  samples_wes: 0.0
  samples_wgs: 0.0
geo_data:
  geo_json:
    coordinates:
    - -71.06
    - 42.36
    type: Point
  info:
    city: Boston
    continent: ''
    country: United States
    label: Boston, United States, North America
    precision: city
journal: Sci Transl Med 3(99), 2011
notes: NA
pmid: '21900593'
title: Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic
  antibody cetuximab.
year: '2011'
